HIQUENCE Trademark

Trademark Overview

On Monday, October 27, 2014, a trademark application was filed for HIQUENCE with the United States Patent and Trademark Office. The USPTO has given the HIQUENCE trademark a serial number of 86435774. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 21, 2018. This trademark is owned by AstraZeneca AB. The HIQUENCE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
hiquence

General Information

Serial Number86435774
Word MarkHIQUENCE
Filing DateMonday, October 27, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 21, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 25, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 5, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Monday, May 21, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 21, 2018ABANDONMENT - NO USE STATEMENT FILED
Thursday, September 21, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 19, 2017EXTENSION 4 GRANTED
Tuesday, September 19, 2017EXTENSION 4 FILED
Tuesday, September 19, 2017TEAS EXTENSION RECEIVED
Friday, April 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 4, 2017EXTENSION 3 GRANTED
Tuesday, April 4, 2017EXTENSION 3 FILED
Tuesday, April 4, 2017TEAS EXTENSION RECEIVED
Tuesday, October 18, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, October 15, 2016EXTENSION 2 GRANTED
Friday, September 23, 2016EXTENSION 2 FILED
Saturday, October 15, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, September 23, 2016TEAS EXTENSION RECEIVED
Saturday, April 16, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 14, 2016EXTENSION 1 GRANTED
Thursday, April 14, 2016EXTENSION 1 FILED
Thursday, April 14, 2016TEAS EXTENSION RECEIVED
Tuesday, October 20, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 25, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 25, 2015PUBLISHED FOR OPPOSITION
Wednesday, August 5, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 17, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, July 17, 2015ASSIGNED TO LIE
Wednesday, July 1, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 30, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 29, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 29, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 16, 2015NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, January 16, 2015PRIORITY ACTION E-MAILED
Friday, January 16, 2015PRIORITY ACTION WRITTEN
Monday, January 12, 2015ASSIGNED TO EXAMINER
Wednesday, November 5, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 30, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

hiquence diseases disorders pharmaceutical preparations nervous system inflammation gastrointestinal infection metabolic